Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Terrance P. Coyne

CFO at Royalty Pharma plc (RPRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $39.0M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 17SEC RPRXRoyalty Pharma plc Sell Plan 9,2301,772 held (−84%) $58.59 $541K -2.8%
Aug 17SEC RPRXRoyalty Pharma plc Sell Plan 1,772 $59.14 $105K -3.7%
May 28SEC RPRXRoyalty Pharma plc Sell Plan 64,399 $53.98 $3.5M +5.5%
Apr 30SEC RPRXRoyalty Pharma plc Sell Plan 32,916 $49.78 $1.6M +14.4%
Apr 30SEC RPRXRoyalty Pharma plc Sell Plan 1,87540,136 held (−4%) $49.78 $93K +14.4%
Apr 2SEC RPRXRoyalty Pharma plc Sell Plan 1,87542,011 held (−4%) $48.33 $91K +17.8%
Apr 2SEC RPRXRoyalty Pharma plc Sell Plan 32,91632,916 held (−50%) $48.33 $1.6M +17.8%
Mar 25SEC RPRXRoyalty Pharma plc Sell Plan 32,91665,832 held (−33%) $45.53 $1.5M +25.0%
Mar 25SEC RPRXRoyalty Pharma plc Sell Plan 1,87543,886 held (−4%) $45.53 $85K +25.0%
Mar 4SEC RPRXRoyalty Pharma plc Sell Plan 22,487109,177 held (−17%) $46.67 $1.0M +22.0%
Mar 4SEC RPRXRoyalty Pharma plc Sell Plan 10,42998,748 held (−10%) $47.01 $490K +21.1%
Mar 4SEC RPRXRoyalty Pharma plc Sell Plan 1,29246,344 held (−3%) $46.67 $60K +22.0%
Mar 4SEC RPRXRoyalty Pharma plc Sell Plan 58345,761 held (−1%) $47.01 $27K +21.1%
Feb 25SEC RPRXRoyalty Pharma plc Sell Plan 32,916131,664 held (−20%) $45.32 $1.5M +25.6%
Feb 25SEC RPRXRoyalty Pharma plc Sell Plan 1,87547,636 held (−4%) $45.32 $85K +25.6%
Feb 4SEC RPRXRoyalty Pharma plc Sell Plan 102,581292,415 held (−26%) $42.08 $4.3M +35.3%
Feb 4SEC RPRXRoyalty Pharma plc Sell Plan 108,759183,656 held (−37%) $42.84 $4.7M +32.9%
Feb 4SEC RPRXRoyalty Pharma plc Sell Plan 19,076164,580 held (−10%) $43.29 $826K +31.5%
Feb 4SEC RPRXRoyalty Pharma plc Sell Plan 5,84330,167 held (−16%) $42.08 $246K +35.3%
Feb 4SEC RPRXRoyalty Pharma plc Sell Plan 6,19523,972 held (−21%) $42.84 $265K +32.9%
Feb 4SEC RPRXRoyalty Pharma plc Sell Plan 1,08722,885 held (−5%) $43.29 $47K +31.5%
Jan 23SEC RPRXRoyalty Pharma plc Sell Plan 65,832394,996 held (−14%) $39.35 $2.6M +44.7%
Jan 23SEC RPRXRoyalty Pharma plc Sell Plan 3,75036,010 held (−9%) $39.35 $148K +44.7%
Jan 6SEC RPRXRoyalty Pharma plc Sell Plan 65,832460,828 held (−12%) $38.42 $2.5M +48.2%
Jan 6SEC RPRXRoyalty Pharma plc Sell Plan 3,75039,760 held (−9%) $38.42 $144K +48.2%
Dec 17SEC RPRXRoyalty Pharma plc Sell Plan 65,832526,660 held (−11%) $38.36 $2.5M +48.4%
Dec 17SEC RPRXRoyalty Pharma plc Sell Plan 3,75043,510 held (−8%) $38.36 $144K +48.4%
Dec 3SEC RPRXRoyalty Pharma plc Sell Plan 65,832592,492 held (−10%) $39.87 $2.6M +42.8%
Dec 3SEC RPRXRoyalty Pharma plc Sell Plan 3,75047,260 held (−7%) $39.87 $150K +42.8%
Nov 26SEC RPRXRoyalty Pharma plc Sell Plan 55,146669,010 held (−8%) $38.67 $2.1M +47.2%
Nov 26SEC RPRXRoyalty Pharma plc Sell Plan 10,686658,324 held (−2%) $37.96 $406K +50.0%
Nov 26SEC RPRXRoyalty Pharma plc Sell Plan 3,12651,634 held (−6%) $38.67 $121K +47.2%
Nov 26SEC RPRXRoyalty Pharma plc Sell Plan 62451,010 held (−1%) $37.96 $24K +50.0%
Nov 19SEC RPRXRoyalty Pharma plc Sell Plan 65,844724,156 held (−8%) $39.30 $2.6M +44.9%
Nov 19SEC RPRXRoyalty Pharma plc Sell Plan 3,75054,760 held (−6%) $39.30 $147K +44.9%
  • Sell

    CFO Terrance P. Coyne sold $541K of RPRX at $58.59 — cuts the stake by 84%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Terrance P. Coyne sold $105K of RPRX at $59.14 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Terrance P. Coyne sold $3.5M of RPRX at $53.98 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Terrance P. Coyne sold $1.6M of RPRX at $49.78 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Terrance P. Coyne sold $93K of RPRX at $49.78 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Terrance P. Coyne sold $91K of RPRX at $48.33 — pre-scheduled 10b5-1 plan sale.